JP2011528354A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528354A5
JP2011528354A5 JP2011518807A JP2011518807A JP2011528354A5 JP 2011528354 A5 JP2011528354 A5 JP 2011528354A5 JP 2011518807 A JP2011518807 A JP 2011518807A JP 2011518807 A JP2011518807 A JP 2011518807A JP 2011528354 A5 JP2011528354 A5 JP 2011528354A5
Authority
JP
Japan
Prior art keywords
piperidinyl
cyclopropyl
dihydro
oxo
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011518807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/050241 external-priority patent/WO2010009014A2/en
Publication of JP2011528354A publication Critical patent/JP2011528354A/ja
Publication of JP2011528354A5 publication Critical patent/JP2011528354A5/ja
Withdrawn legal-status Critical Current

Links

JP2011518807A 2008-07-15 2009-07-10 抗生物質 Withdrawn JP2011528354A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8080908P 2008-07-15 2008-07-15
US61/080,809 2008-07-15
PCT/US2009/050241 WO2010009014A2 (en) 2008-07-15 2009-07-10 Antibiotic drug

Publications (2)

Publication Number Publication Date
JP2011528354A JP2011528354A (ja) 2011-11-17
JP2011528354A5 true JP2011528354A5 (cg-RX-API-DMAC10.html) 2012-08-09

Family

ID=41550976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011518807A Withdrawn JP2011528354A (ja) 2008-07-15 2009-07-10 抗生物質

Country Status (6)

Country Link
US (1) US20120157492A1 (cg-RX-API-DMAC10.html)
JP (1) JP2011528354A (cg-RX-API-DMAC10.html)
KR (1) KR20110050623A (cg-RX-API-DMAC10.html)
CN (1) CN101628911B (cg-RX-API-DMAC10.html)
TW (1) TW201008567A (cg-RX-API-DMAC10.html)
WO (1) WO2010009014A2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
EA018653B1 (ru) 2008-07-01 2013-09-30 Тайджен Байотекнолоджи Ко., Лтд. Лечение инфекций, вызванных антибиотикоустойчивыми бактериями
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
RU2671496C2 (ru) 2013-10-14 2018-11-01 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производные 5-пиперидин-8-цианохинолина
CN106336371A (zh) * 2016-08-16 2017-01-18 成都百事兴科技实业有限公司 叔丁氧羰基‑l‑焦谷氨酸甲酯的合成方法
CN113640416A (zh) * 2021-08-12 2021-11-12 海南海神同洲制药有限公司 盐酸左氧氟沙星片的含量测定方法
CN116785271A (zh) * 2023-07-13 2023-09-22 河南农业大学 苹果酸及其衍生物在制备金属-β-内酰胺酶增敏剂中的应用、组合物和其应用
CN118852222B (zh) * 2024-06-27 2025-09-05 南京桦冠生物技术有限公司 一种奈诺沙星中间体及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135036A0 (en) * 1997-09-15 2001-05-20 Procter & Gamble Antimicrobial quinolones, their compositions and uses
MX2008012327A (es) * 2006-03-28 2008-10-09 Procter & Gamble Un proceso de reduccion con hidruro para preparar intermedios de quinolona.

Similar Documents

Publication Publication Date Title
JP2011528354A5 (cg-RX-API-DMAC10.html)
JP2013047268A5 (cg-RX-API-DMAC10.html)
JP2012506871A5 (cg-RX-API-DMAC10.html)
WO2010036876A3 (en) Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
JP2011530534A5 (cg-RX-API-DMAC10.html)
JP2015504921A5 (cg-RX-API-DMAC10.html)
JP2012513467A5 (cg-RX-API-DMAC10.html)
JP2013253094A5 (cg-RX-API-DMAC10.html)
IL272888B2 (en) Novel uses of piperidinyl-indole derivatives
NZ702796A (en) Immunogenic anti-inflammatory compositions
WO2015089073A3 (en) Compositions and methods for phagocyte delivery of anti-staphylococcal agents
RU2018114480A (ru) Соли и твердые формы монобактамного антибиотика
JP2012506870A5 (cg-RX-API-DMAC10.html)
JP2013539751A5 (cg-RX-API-DMAC10.html)
JP2009503024A5 (cg-RX-API-DMAC10.html)
HRP20191295T1 (hr) Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih
JP2017519730A5 (cg-RX-API-DMAC10.html)
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2014022382A3 (en) Antibacterial protein kinase inhibitors
JP2014520077A5 (cg-RX-API-DMAC10.html)
RU2013137752A (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины
JP2011526887A5 (cg-RX-API-DMAC10.html)
JP2010507576A5 (cg-RX-API-DMAC10.html)
JP2008520660A5 (cg-RX-API-DMAC10.html)
JP2024009968A5 (cg-RX-API-DMAC10.html)